Neoadjuvant selpercatinib for advanced medullary thyroid cancer. Jozaghi Y, Zafereo M, Williams MD, Gule-Monroe MK, et al. Head Neck 2021;43:E7-E12.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jozaghi Y, Zafereo M, Williams MD, Gule-Monroe MK, et al. Neoadjuvant selpercatinib for advanced medullary thyroid cancer. Head Neck 2021;43:E7-E12.
PMID: 33169506